标题:Effects of herb-partitioned moxibustion for ulcerative colitis A protocol for systematic review and meta-analysis
作者:Yan, Xiao; Ma, Fengjun; Yu, Yanpu; Du, Dongqing; Wang, Zhilei; Chen, Chen; Zhang, Xiaobin; Sun, Xiao; Dong, Zhibin; Ma, Yuxia; Ma, 更多
作者机构:[Yan, Xiao; Ma, Fengjun; Yu, Yanpu; Du, Dongqing; Wang, Zhilei; Chen, Chen; Zhang, Xiaobin; Sun, Xiao; Dong, Zhibin; Ma, Yuxia; Ma, Yuning] Shandong U 更多
通讯作者地址:Ma, YX; Ma, YN (corresponding author), Shandong Univ Tradit Chinese Med, Dept Tradit Chinese Med, 4655 Univ Rd, Jinan 250355, Shandong, Peoples R Chin 更多
来源:MEDICINE
出版年:2020
卷:99
期:31
DOI:10.1097/MD.0000000000021319
关键词:herb-partitioned moxibustion; meta-analysis; protocol; systematic; review; ulcerative colitis
摘要:Background: Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease of the colonic mucosa. Herb-partitioned moxibustion (HPM) treatment has been demonstrated to be effective in the treatment of UC. However, there is still a lack of high-quality evidence to support the effectiveness and safety of HPM on patients with UC. This study will aim to systematically explore the efficacy of HPM for the treatment of UC. Methods: We will search the electronic databases of Embase, MEDLINE, PubMed, Cochrane Library Central Register of Controlled Trials, China national knowledge infrastructure database (CNKI), Wan fang database, Chongqing VIP information, and SinoMed from their inception to June 2020. Randomized controlled trials (RCTs) of HPM for the treatment of UC will be included. RevMan 5.3 software (The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen, Denmark) will be applied for statistical analysis. Results: The results of this study will be published in a peer-reviewed journal. Conclusion: The conclusion of our systematic review will provide more appropriate evidence-based decisions to assist clinicians during the decision-making process when dealing with UC.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089171415&doi=10.1097%2fMD.0000000000021319&partnerID=40&md5=3826195a11d2d7f6f495bcd99035d066
TOP